PFND OTC
Pathfinder Cell Therapy, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -94.4%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.000001-0.0001
Volume500
Avg Volume467
Beta1.07
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORichard L. Franklin
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2000-01-03
Websitepathfindercelltherapy.com
12 Bow Street
Cambridge, MA 02138
US
Cambridge, MA 02138
US
617-245-0289
About Pathfinder Cell Therapy, Inc.
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Latest News
No recent news
Recent Insider Trades
No insider trades found